CVS Health Corp (CVS) Stock Forecast & Price Target
CVS Health Corp · NYSE
$109.37+2.30 (+2.15%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering CVS Health Corp, 17 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $90.00 to $123.00, so the covering firms are broadly aligned. The average target of $108.94 is roughly in line with the current $109.37. The rating mix has stayed broadly stable, with Buy-side ratings easing from 18 to 17 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.71 next quarter toward $8.42 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Moderate Buy
Strong Buy00%
Buy17100%
Hold00%
Sell00%
Strong Sell00%
Based on 17 analysts giving stock ratings to CVS Health Corp.
As of Jul, 17 of 17 firms rate CVS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CVS EPS & revenue forecast
EPS · NEXT QUARTER
$1.71
Range $1.56 – $1.82 · 23 analysts · +7% YoY
Next period, 23 analysts expect CVS Health Corp to earn $1.71 a share (range $1.56 – $1.82), versus $1.60 a year earlier. Full-year consensus is $7.45, growing to $8.42 the year after.
REVENUE · NEXT QUARTER
$103.4B
Range $101.4B – $108.5B · 23 analysts · +1% YoY
Revenue is expected to reach $103.4B (range $101.4B – $108.5B), +0.5% year-over-year. Full-year consensus is $409.4B, rising to $426.7B next year.
Top analysts covering CVS Health Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CVS.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
$118.00+7.9% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$113.00+3.3% to target
Overall win rate
44%
+ Follow
#3
Kevin Caliendo
UBS
Buy
$122.00+11.5% to target
Coverage
—
+ Follow
#4
Ann Hynes
Mizuho
Buy
$120.00+9.7% to target
Coverage
—
+ Follow
#5
LW
Lance Wilkes
Bernstein
Buy
$106.00-3.1% to target
Coverage
—
+ Follow
CVS stock forecast FAQ
What is CVS's average 12-month price target?+
The 16 analysts with a live target average $108.94 for CVS Health Corp over the next 12 months, ranging from a $123.00 high to a $90.00 low.
Is CVS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 17 analyst ratings, 17 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CVS?+
The Street-high target is $123.00 (Wells Fargo), and the Street-low is $90.00 (Argus Research). The average of all 16 active targets is $108.94.
How many Wall Street analysts cover CVS?+
17 analysts have an active rating on CVS Health Corp, and 16 firms carry a live 12-month price target.
Who is the most accurate analyst covering CVS?+
Among analysts who currently cover CVS, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy with a $118.00 target.
What is CVS Health Corp's projected EPS for next quarter?+
The consensus estimate is $1.71 per share (range $1.56 – $1.82) across 23 analysts. Full-year EPS is projected at $7.45, rising to $8.42 the following year.
How much revenue is CVS Health Corp expected to report next quarter?+
Consensus revenue is $103.4B (range $101.4B – $108.5B). Full-year revenue is projected at $409.4B, growing to $426.7B next year.
Have analysts been upgrading or downgrading CVS lately?+
As of Jul, 17 of 17 firms rate CVS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
